The Importance Of Eye Vision To Americans
Belmont Eye Center News,Featured
From seeing the faces of loved ones, to watching the sun come up and go down — these are a few things that Americans will most miss seeing if they lose sight. A new survey of 2000 Americans found respondents also would miss seeing their childs milestones (26%), nature (23%), their pets (22%), and their…
Read More
How To Find The Best LASIK Surgeon In NYC
Belmont Eye Center News,Featured
Before going in for any type of surgery, you need to consider risks, what to expect, and, above all, how to find a reputable LASIK surgeon. We want to make sure your laser eye surgery is a great experience for you, so we have compiled the reasons why Dr. Sandra Belmont is the best surgeon…
Read More
What Your Eye Color Can Say About Your Health
Researchers found people who had vitiligo were less likely to have blue or grey eyes compared with people who did not. A 2012 review of research on vitiligo published in Nature found the autoimmune disorder, which causes a loss of skin color to mottled patches, was less prevalent in blue-eyed people. You are also a…
Read More
Streamlining stem cells to treat macular degeneration
[ad_1] As we age, so do our eyes; most commonly, this involves changes to our vision and new glasses, but there are more severe forms of age-related eye problems. One of these is age-related macular degeneration, which affects the macula — the back part of the eye that gives us sharp vision and the ability…
Read More
Aflibercept shown to work at higher dose, longer intervals
[ad_1] Regeneron Pharmaceuticals Inc. this week announced that the primary endpoints were met in two pivotal trials investigating novel aflibercept 8 mg (Eylea) with 12- and 16-week dosing regimens in patients with diabetic macular edema (DME) and wet age-related macular degeneration (wAMD). The PHOTON trial in DME and the PULSAR trial in wAMD both demonstrated…
Read More
First U.S. patient receives autologous stem cell therapy to treat dry AMD
[ad_1] The National Institutes of Health (NIH) announced the first patient has been treated in its phase 1/2a clinical trial (NCT04339764) of an autologous induced pluripotent stem cell (iPSC) therapy for the treatment of dry age-related macular degeneration (AMD).1 According to an NIH news release, the patient received the therapy as part of a clinical…
Read More
Research focuses on retinal issues following COVID-19 infection
[ad_1] Retinal involvement following a COVID-19 infection is rare but can happen after severe infections in immunocompetent individuals, according to Yusar Asad, MD, and colleagues from the Vitreoretinal Services, Centre for Sight, Delhi, India. The research team conducted a retrospective review of consecutive patients presenting with retinal manifestations attributable to COVID 19 between May 2020…
Read More
More than 26,000 eye injuries related to sports treated last year
[ad_1] Prevent Blindness has declared September as Sports Eye Safety Month to help educate the public on the importance of wearing the proper eye protection while playing sports. According to data from Prevent Blindness, there were more than 26,000 sports-related eye injuries treated in the United States last year. The new data also showed that…
Read More
Alternative topical ocular antiseptic lowers bacterial load with less pain
[ad_1] Reviewed by Thomas W. Hejkal, MD, PhD Because many people are very sensitive to povidone-iodine 5% (Betadine; Alcon), Thomas Hejkal, MD, PhD, and colleagues set out to identify an alternative ocular antiseptic with the potential to cause fewer ocular problems for their patients that is also as effective at eradicating surface bacteria. Hejkal is…
Read More
Gene therapy for completely colorblind children partly restores cone function
[ad_1] Gene therapy has partly restored the function of the retina’s cone receptors in two children who were born completely colorblind, reports a new study led by UCL researchers. The findings, published in Brain,1 provide hope that the treatment is effectively activating previously dormant communication pathways between the retina and the brain, drawing on the plastic…
Read More
Our Location
121 E 61st St.
New York, NY 10065
© Belmont Eye Center all rights reserved 2025. Designed by Glacial Multimedia.
If you are using a screen reader and are having problems using this website, please call 212.486.2020.